How long will it take to reduce gastric cancer incidence by eradicating helicobacter pylori infection?

Cancer Prevention Research

Volumn 6, Issue 7, 2013, Pages 695-700

  Osborn, John F ^a   Cattaruzza, Maria S ^a   Ferri, Anna M ^a   Angelis, Flora De ^a   Renzi, Davide ^a   Marani, Alessandra ^a   Vaira, Dino ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; NORMAL DISTRIBUTION; PRIORITY JOURNAL; STOMACH CANCER; TIME; AGE; COMPLICATION; DRUG EFFECTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INCIDENCE; ISOLATION AND PURIFICATION; ITALY; MICROBIOLOGY; PROGNOSIS; RISK FACTOR; STOMACH NEOPLASMS;

ANTIINFECTIVE AGENT;

AGE FACTORS; ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; ITALY; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS;

EID: 84880079437     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0428     Document Type: Article

References (19)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010 [cited 2012 Nov 7]. Available from: http://globocan.iarc.fr.
2. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13:607-15.
3. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362:1597-604.
4. Richardson R. Interview: chance favours the prepared mind. Lancet 2006;368:S46-S47.
5. IARC. Monographs on the evaluation of carcinogenic risks to humans. Vol. 61, Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: International Agency for Research on Cancer; 1994.
6. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:121-8.
7. Ford CA, Moayyedi P. Redundant data in the Meta-analysis on Helicobacter pylori eradication. Ann Int Med 2009;151-513.
8. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al. Fifteen-year effect of Helicobacter pylori, garlic and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012;104: 488-92.
9. Lee Y-C, Chen TH-H, Chiu H-M, Shun C-T, Chiang H, Liu T-Y, et al. The benefit of mass eradication of Helicobacter pylori infection: a community- based study of gastric cancer prevention. Gut 2013:62; 676-82.
10. Fassan M, Pizzi M, Farinati F, Nitti D, Zagonel V, Genta RM, et al. Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am J Clin Pathol 2012;137:727-32.
11. Rugge M, Fassan M, Graham DY. Clinical guidelines: secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol 2012; 3:128-9.
12. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
13. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012;13:2-5.
14. Vaira D, Malfertheiner P, Megraud F, Axon ATR, Deltenre M, Hirschl A, et al. European Helicobacter pylori HPSA study group. Diagnosis of Helicobacter pylori infection using a novel, non-invasive antigen based assay in a European multicentre study. Lancet 1999;354:30-3.
15. Vakil N, Zullo A, Ricci C, Hassan C, Vaira D. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients. Aliment Pharmacol Ther 2008;28:1304-8.
16. Vaira D, Zullo A, Vakil N, Gatta L, Ricci C, Perna F, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med 2007;146:556-63.
17. Parkin M. Cancers attributable to infection in the UK in 2010. Br J Cancer 2011;105:S49-S56.
18. Marinelli M, Bianucci F, Leone E. Trends in mortality from stomach tumors in Italy from 1951-1981. Ann Ig 1989;1:109-24.
19. Stracci F, Moffa IF, Montefusco C, Minelli L, Falsettini E, La Rosa F. Trends in gastric cancer incidence, mortality and survival in theUmbria region of Italy 1978-82 and 1994-99. Ann Ig 2004;16:665-72.